Trials of new cancer drug Venetoclax show promising outcomes for leukaemia

By Rania Spooner
Updated February 2 2016 - 10:13am, first published January 28 2016 - 9:03am

Australian cancer patients are currently testing a promising new drug targeting advanced forms of leukaemia, one of the most common of blood cancers.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Ballarat news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.